Market Data 
Markets
Replies to post #617598 on NorthWest Biotherapeutics Inc (NWBO)
08/06/23 3:36 PM
Overall Survival
— Carlo Rago, PhD (@rago_carlo) February 22, 2023
2.1 months, median benefit for 71 FDA approved solid tumor drugs, from 2002-2014 (only 42% of these met ASCO criteria for "clinically meaningful improvement")
5.4 months, DCVax-L benefit in rGBM (13.2 v 7.8, a 69% gain)
2.8 months, https://t.co/As5IbE83Fv…
Re: LessIsMore Post# 197563
Dr Rago's background + disclosure of owning NWBO shares should be taken IMHO as a BIG POSITIVE.
Dr. Rago would not be owning NWBO UNLESS he felt it was undervalued.
He had the option of not purchasing shares
.
Since iI wasn't stated whether he was paid shares for his white paper abstract one has to presume that
he got paid in $ by Bigger Capital and District 2 et al Funds.
At the very least he is motivated and incentivized for PRODUCING RESULTS and has an aligned vested
interest! like CEO Linda Powers; Bigger Capital , us here
OBVIOUSLY with Dr. Rago's stature and what's been finally happening within his profession it is mandatory
that such disclosures are disclosed UPFRONT unlike what happened to the former prominence of the influential trend setting Sloan Memorial Kettering Institute (especially in ONCOLOGY where my deceased father life was spared by colon cancer at the unheard of age of 85 that I correctly diagnosed why: ACID test verified by a Duke Univ MD friend) where Sloan Memorial Kettering Institute's bureaucracy got caught with not reigning in their CMO last month with his conflict of interest shenanigans going back a decade!
https://www.nytimes.com/2018/10/01/health/cancer-memorial-sloan-kettering-ethics.html
DIFFERENT STROKES FOR DIFFERENT FOLKS
Replies:
Thank you maverick. Agreed.
sentiment_stocks on 11/15/2018 7:43:53 PM
Agreed.
sukus on 11/15/2018 10:55:09 PM
Michael Bigger & Eric Schlanger of BiggerCapital et
maverick_1 on 11/18/2018 12:13:58 PM
Re: maverick_1 Post# 197678
Michael Bigger & Eric Schlanger of BiggerCapital et al have intriguing backgrounds and requisite skill sets highlighting BOTH why their funds did a SECOND private placement and why CEO Linda Powers choose them after the Neil Woodford & Funds FIASCO.....and it is BEYOND just the money IMHO!
I am flabbergasted and truly appalled that no one here, even explored, nor posted to my knowledge, any of what I am asserting above. It also speaks to the clear inertia, timid nature of both beaten up shareholders....to those with the consistency of one sentence come ons : the ultimate tease using his Twitter feed only! that prompts his posting.
Truly a sad ongoing saga here! So lacking in credentials and requisite background also account for No hoospa. Very few IMHO have had the right tires or equipment for this long journey into either Canyon-lands Natl Park let alone deep into the Amazon jungle.
Michael Bigger and Eric Schlanger have both the resources, the background of being Contrarian long term value hunters that CEO Linda Powers will have comfort with after Neil Woodford FIASCO. They are not vulture capitalists and surely not passive. Instead they are well equipped to do high profile battles with the likes of AFRAUDSTEIN etc.
A specific example that makes the point of the above Eric Schlanger was the Equity Head for Barclay’s which mean both Research and more importantly IMHO head of Institutional Sales, where with his mindset and skills he could easily drum up interest “sub Rosa like institutional interest” unlike what Larry Smith has yet to demonstrate or do! From his Linked In Bio:
—————————————————————————————-
“Barclays Investment Bank
9 years 8 months
Head of Equities, Americas
Barclays Investment Bank
December 2013 – April 2018 4 years 5 months
Greater New York City Area
Manage sales and trading organization, set overall strategy and point person for all regulatory / legal matters. Responsible for overall portfolio risk across all equities products in the region to include derivatives, convertibles, cash and ECM residual positions. Senior client relationships to include Hedge Fund Founders, CIOs, Head Traders, Long Only Managers and Asset Allocators. Identify and cultivate talent, set standards of excellence, lead and mentor in an ever-changing world. Flow derivative expert and student of the financial markets. Member BI Diversity Council and Member BCI Board.
Co-Head Equities Distribution, Americas
Barclays Capital
March 2012 – December 2013 1 year 10 months
Set client strategy across all equites products.
Manage personnel, distribution structure, and client outcomes.
Senior client relationships to include Hedge Fund Founders, CIOs, Head Traders, Long Only Managers and Asset Allocators”
——————————————————————————————
Additionally Eric Schlanger may be helpful to Board member and shareholder Coffer Black as Barclay’s wanted business from the Hedge Fund community so Barclay’s instituted online DARK POOL for Naked Short Selling!
So over the four years on this board I’ve demonstrated that it does pay monetarily and intellectually in many ways to go outside the science as many of you have found out the hard way!
BUT IMHO investing is an art form of dealing with a myriad of cross currents. FEW succeed due to their pre dispositions and mindset as amply demonstrated over the last 4 or more years.
DIFFERENT STROKES FOR DIFFERENT FOLKS
This guy knows how to fix a broken heart🫶 pic.twitter.com/yaFth6Xkpf
— Tansu Yegen (@TansuYegen) August 6, 2023
